UPM Pharmaceuticals
Founding PartnerIs this your company? Claim this profile
Drug Product
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Company Overview
About
UPM Pharmaceuticals is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:United States
Founded:2002
Employees:509
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
North America
Europe
Manufacturing Facilities
1 site worldwide
Gregory Pharmaceutical Holdings, Inc., dba UPM Pharmaceuticals
501 5th St, Bristol, Tennessee, 37620-2304
Site Capabilities
4 capabilitiesANALYSIS
LABEL
MANUFACTURE
PACK
Regulatory Approvals
Drug Approval EEWRVF
Health Canada · #APR-QH0LVIHY · 2021-07-01
Drug Approval VZVHXW
PMDA · #APR-OFCGYK7E · 2019-09-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-7ETWDEQI
Issued: 2020-11-27
Expires: 2025-09-07
WHO GMP
World Health Organization
Cert #: CERT-ACKPXTKR
Issued: 2020-05-11
Expires: 2025-07-26
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-E7323DFM
Issued: 2020-02-19
Expires: 2025-05-07
Health Canada GMP
Health Canada
Cert #: CERT-5H9ARTIV
Issued: 2020-06-02
Expires: 2025-05-02
Loading CDMO intelligence...
Key facts about UPM Pharmaceuticals
- UPM Pharmaceuticals is headquartered in the United States.
- UPM Pharmaceuticals was founded in 2002.
- UPM Pharmaceuticals has 509 employees.
- UPM Pharmaceuticals has one manufacturing site listed on CDMO Hub, in Bristol, United States.
- UPM Pharmaceuticals's capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Specialty pages
Dedicated, in-depth pages for UPM Pharmaceuticals’s core service areas.
Oral Solid Dose ManufacturingUPM Pharmaceuticals provides end-to-end development and manufacturing for oral solid dosage forms — tablets and capsules — from early clinical batches through full commercial supply. As an independent US CDMO operating a cGMP facility in Bristol, Tennessee, UPM supports immediate-release and modified-release products, process optimization, packaging, and ongoing product lifecycle management under one roof.View specialty →Technology Transfer & Scale-UpTechnology transfer is one of UPM Pharmaceuticals’ core areas of expertise. UPM works with pharmaceutical innovators, virtual biotech companies, and development-stage organizations seeking a manufacturing partner to carry a product from development environments into later-stage clinical and commercial production — reducing execution risk and accelerating time to market.View specialty →
Find CDMOs like UPM Pharmaceuticals
Directory pages this company appears in, each with the full list of matching manufacturers.